A type 2 diabetes submission is planned but not yet approved
The primary mechanisms of action include: Enhanced insulin secretion : GLP-1 receptor agonists stimulate glucose-dependent insulin release from pancreatic beta cells, improving glycaemic control without causing hypoglycaemia when glucose levels are normal Suppressed glucagon secretion : These agents inhibit inappropriate glucagon release from pancreatic alpha cells, reducing hepatic glucose production Delayed gastric emptying : By slowing the rate at which food leaves the stomach, GLP-1 medications prolong satiety and reduce postprandial glucose excursions Central appetite regulation : GLP-1 receptors in the hypothalamus and brainstem mediate reduced appetite and food intake, leading to decreased caloric consumption Regarding visceral fat specifically, some imaging substudies suggest GLP-1 receptor agonists may reduce visceral adipose tissue alongside subcutaneous fat
doi: 10.1016/j.emc.2025.08.011 [PubMed]
That said, its BBB rating of 1.19/5 reflects real, documented complaints about slow service and unclear pricing, so go in with clear expectations
While compounded drugs are always supposed to contain FDA-approved ingredients, the formulations as prepared at compounding pharmacies aren't reviewed by the FDA for purity, safety, or effectiveness
A healthy gut environment translates directly to a more efficient metabolism and a stronger immune system